Blincyto contains Blinatumomabe, 38.5mcg, supplied as injection (powder). Manufacturer: Amgen / AstraZeneca India. Therapeutic class: BiTE (CD19xCD3).
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.